Charles River Labs cuts expansion plans by $140M
The change is a result of “unforeseen regulator and economic uncertainties associated with the specialized health manufacturing industry,” according to documents.
There are 2 article(s) tagged Charles River Laboratories:
The change is a result of “unforeseen regulator and economic uncertainties associated with the specialized health manufacturing industry,” according to documents.
Boston-based Charles River Laboratories manufactures clinical and commercial cell and gene-modified cell therapies at its Shelby Drive facility.
About 2 results